Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
12.78
-1.82 (-12.47%)
At close: Apr 29, 2026, 4:00 PM EDT
12.94
+0.16 (1.25%)
After-hours: Apr 29, 2026, 4:26 PM EDT
Tenax Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 751 | 495 | 218 | 7 | 5 | 26 | |
| Market Cap Growth | 3298.16% | 126.39% | 3233.86% | 31.60% | -81.01% | 11.69% | |
| Enterprise Value | 656 | 395 | 120 | -4 | 1 | 18 | |
| Last Close Price | 14.60 | 12.19 | 6.19 | 21.97 | 178.24 | 1664.00 | |
| PB Ratio | 6.38 | 5.10 | 2.38 | 0.81 | 3.34 | 6.18 | |
| P/TBV Ratio | 7.76 | 5.10 | 2.38 | 0.81 | 3.34 | 6.18 | |
| Debt / Equity Ratio | - | - | - | 0.06 | 0.54 | 0.07 | |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -1.03 | -1.15 | -0.88 | -1.25 | |
| Net Debt / EBITDA Ratio | - | - | 4.87 | 1.13 | 0.12 | 0.17 | |
| Net Debt / FCF Ratio | 2.73 | 2.73 | 6.40 | 1.57 | 0.12 | 0.49 | |
| Quick Ratio | 13.63 | 13.63 | 20.21 | 2.73 | 1.15 | 3.57 | |
| Current Ratio | 14.57 | 14.57 | 20.60 | 3.26 | 1.74 | 3.64 | |
| Return on Equity (ROE) | -55.64% | -55.64% | -35.17% | -160.80% | -385.12% | -732.21% | |
| Return on Assets (ROA) | -35.08% | -35.08% | -22.48% | -68.21% | -147.02% | -306.43% | |
| Return on Capital Employed (ROCE) | -58.10% | -58.10% | -21.20% | -101.70% | -709.90% | -712.00% | |
| Earnings Yield | -6.98% | -10.64% | -8.06% | -117.68% | -221.89% | -123.88% | |
| FCF Yield | -4.75% | -7.24% | -6.78% | -90.10% | -228.78% | -41.43% | |
| Buyback Yield / Dilution | -156.80% | -156.80% | -6046.87% | -1250.92% | -43.00% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.